BUB1B and cervical squamous intraepithelial neoplasia: Altogether, our studies suggest that patients carrying the variant c.1117_1173del, or potentially other “deleterious” variants in the BUB1B gene, may benefit from pretherapeutic assessment of CIN/PCS to optimize treatment stratification and clinical trial design.